Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Contract Development Manufacturing Organizations Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The contract development manufacturing organizations market size has seen significant growth in recent years. It is anticipated to expand from $274.79 billion in 2025 to $309.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.8%. The historical growth of this market can be attributed to several factors, including cost optimization through outsourcing, increased research and development expenditure in pharmaceuticals, the rising production of generic drugs, escalating regulatory complexity, and limited in-house manufacturing capacity.
The contract development manufacturing organizations market size is anticipated to experience significant expansion over the upcoming years. It is projected to reach $503.82 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This anticipated growth during the forecast period is primarily driven by factors such as the expansion of biologics and advanced therapies, a heightened need for adaptable manufacturing capabilities, the increasing presence of small and mid-size pharmaceutical enterprises, a surge in clinical trial activities, and the overall growth of the global pharmaceutical pipeline. Key trends expected during this period involve a greater reliance on outsourcing for drug development and production, an escalating demand for comprehensive CDMO services, the broadening of biologics and biosimilars manufacturing, an enhanced emphasis on regulatory adherence and quality control, and the expansion of production capabilities within developing pharmaceutical markets.
Get A Free Sample Report With In-Depth Market Insights:
Contract Development Manufacturing Organizations Market Industry Drivers: What’s Behind The Revenue Growth?
The expansion of the contract development manufacturing organizations market is significantly influenced by the increasing need for pharmaceutical products, which stems from the rise in chronic diseases and the growth of the geriatric population. This increase in chronic diseases and the elderly population has enabled pharmaceutical companies to expedite the manufacturing of biologics and biosimilars. Consequently, most pharmaceutical firms have opted to contract production and manufacturing organizations on a contractual basis to manage and coordinate their company’s tasks, operations, and tests. For example, in November 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, reported that the total pharmaceutical production in Europe reached €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Thus, the escalating demand for pharmaceutical products acts as a primary driver for the growth of the contract development manufacturing organizations market.
Contract Development Manufacturing Organizations Market Segmentation And Category Overview
The contract development manufacturing organizations market covered in this report is segmented –
1) By Service: CMO, CRO
2) By Product: Small Molecules, Biologics
3) By End User: Big Pharma, Small and Mid-size Pharma, Generic Pharmaceutical Companies, Other End Users
Subsegments:
1) By CMO (Contract Manufacturing Organization): API (Active Pharmaceutical Ingredient) Manufacturing, Formulation Development, Finished Product Manufacturing, Packaging Services
2) By CRO (Contract Research Organization): Preclinical Research Services, Clinical Trial Management, Data Management And Biostatistics, Regulatory Affairs Consulting
#Contract Development Manufacturing Organizations Market Growth Trends: What’s Shaping The Future Outlook?
Major companies operating in the contract development and manufacturing organizations market are emphasizing innovative initiatives like Lifera to generate revenue. Lifera functions as a commercial-scale contract development and manufacturing organization (CDMO). For instance, in June 2023, the Public Investment Fund (PIF), Saudi Arabia’s global investment organization, established Lifera. Lifera’s primary focus will be on producing vital biopharmaceutical products, such as insulin, vaccinations, monoclonal antibodies, plasma treatments, cell and gene therapies, and cutting-edge small chemicals. To expand local capabilities and support domestic manufacturing in this sector, the company will also form alliances with leading domestic and foreign businesses and attract specific investments. Advancing formulation development, medication development, and manufacturing are among Lifera’s key objectives.
Contract Development Manufacturing Organizations Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the contract development manufacturing organizations market are Recipharm AB, AbbVie Contract Manufacturing LLC, Almac Group Limited, Baxter BioPharma Solutions LLC, Boehringer Ingelheim International GmbH, Catalent Pharma Solutions Inc., CMIC Holdings Co. Ltd., Covance Inc., Evotec SE, Famar Health Care Services Madrid SA, Jubilant Life Sciences Limited, Lonza Group Ltd., Patheon UK Limited, Pfizer CentreOne, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, Advanced BioScience Laboratories Inc., Adare Pharmaceuticals Inc., Aenova Holding GmbH, Ajinomoto Bio-Pharma Services, Albany Molecular Research Inc., Cambrex Corporation, CordenPharma International GmbH, EirGen Pharma Limited, Grand River Aseptic Manufacturing, Hovione LLC, Metrics Contract Services, NextPharma Technologies Holding Limited, Nitto Avecia Pharma Services Inc., Piramal Pharma Solutions Inc., Siegfried Holding AG, Therapure Biopharma Inc., Velesco Pharmaceutical Services, WuXi PharmaTech (Cayman) Inc.
View The Full Contract Development Manufacturing Organizations Market Report:
Contract Development Manufacturing Organizations Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in contract development manufacturing organizations market in 2025. The regions covered in the contract development manufacturing organizations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
